Recent Progress in Hydrogen-mediated Neuroprotection via Modulation of Mitochondrial Quality Control Mechanisms in Brain Injury
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This 2026 narrative review concludes that molecular hydrogen has shown neuroprotective effects across experimental brain-injury models and highlights mitochondrial quality control as a major mechanistic theme. It is a synthesis of prior studies, not a new clinical efficacy trial.
What the Findings Mean
The review supports mitochondrial quality control as one plausible framework linking hydrogen exposure to neuroprotection, while emphasizing that the evidence spans heterogeneous experimental models and is not equivalent to established clinical efficacy.
What the Researchers Studied
The authors reviewed molecular-hydrogen research in ischemic stroke, traumatic brain injury, hypoxic-ischemic encephalopathy, intracerebral hemorrhage, subarachnoid hemorrhage, chronic cerebral hypoperfusion, and toxic encephalopathy, with emphasis on mitochondrial quality control.
What Effects Did Molecular Hydrogen Have?
Across the literature reviewed, hydrogen was associated with antioxidant, anti-inflammatory, anti-apoptotic, and mitochondrial-protective effects, including effects on mitophagy, mitochondrial dynamics, membrane protection, and metabolic regulation.
Why These Findings Matter
The review supports mitochondrial quality control as one plausible framework linking hydrogen exposure to neuroprotection, while emphasizing that the evidence spans heterogeneous experimental models and is not equivalent to established clinical efficacy.
How Strong Is This Evidence?
Narrative review. It is useful for mechanism and literature synthesis but does not provide an independent randomized clinical effect estimate.
Technical Study Details
Model: Review of experimental and translational brain-injury literature
DOI: 10.2174/0115672026430179251224095358
Limitations and Safety
Limitations: The review itself identifies unresolved scientific questions, model limitations, and the need for stronger clinical translation. Review conclusions depend on the quality and heterogeneity of the underlying studies.
Safety: No new treatment cohort was enrolled, so this review does not provide a new adverse-event estimate.
Original Study and H2HUBB Research Context
This publication is an exact-identity member of H2HUBB Gold v1.1.4. The materialized summary is bounded to the certified source evidence used for this import. Source basis: PubMed abstract and publisher abstract. Original/source record.